Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Guérin AP[au]:

Ankle-brachial index and bone turnover in patients on dialysis. London GM et al. J Am Soc Nephrol. (2015)

Calcification of the aortic valve in the dialyzed patient. London GM et al. J Am Soc Nephrol. (2000)

Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Souberbielle JC et al. Autoimmun Rev. (2010)

Search results

Items: 1 to 50 of 80

1.

Ankle-brachial index and bone turnover in patients on dialysis.

London GM, Marchais SJ, Guérin AP, de Vernejoul MC.

J Am Soc Nephrol. 2015 Feb;26(2):476-83. doi: 10.1681/ASN.2014020169. Epub 2014 Sep 17.

2.

Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.

Amabile N, Guérin AP, Tedgui A, Boulanger CM, London GM.

Nephrol Dial Transplant. 2012 May;27(5):1873-80. doi: 10.1093/ndt/gfr573. Epub 2011 Oct 29.

PMID:
22036944
3.

Flow-mediated vasodilation in end-stage renal disease.

Verbeke FH, Pannier B, Guérin AP, Boutouyrie P, Laurent S, London GM.

Clin J Am Soc Nephrol. 2011 Aug;6(8):2009-15. doi: 10.2215/CJN.01260211. Epub 2011 Jul 22.

4.

Central artery pulse pressure in end-stage renal disease: the roles of aortic diameter, aortic stiffness and wave reflection.

Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM.

Blood Purif. 2011;31(1-3):107-12. doi: 10.1159/000322104. Epub 2011 Jan 10.

5.

Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice.

Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff-Ferrari HA, Cavalier E, Ebeling PR, Fardellone P, Gandini S, Gruson D, Guérin AP, Heickendorff L, Hollis BW, Ish-Shalom S, Jean G, von Landenberg P, Largura A, Olsson T, Pierrot-Deseilligny C, Pilz S, Tincani A, Valcour A, Zittermann A.

Autoimmun Rev. 2010 Sep;9(11):709-15. doi: 10.1016/j.autrev.2010.06.009. Epub 2010 Jul 1.

6.

Assessment and significance of arterial stiffness in patients with chronic kidney disease.

Guérin AP, Pannier B, Métivier F, Marchais SJ, London GM.

Curr Opin Nephrol Hypertens. 2008 Nov;17(6):635-41. Review.

PMID:
19031658
7.

Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.

London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC.

J Am Soc Nephrol. 2008 Sep;19(9):1827-35. doi: 10.1681/ASN.2007050622. Epub 2008 May 14.

8.

Arterial structure and function in end-stage renal disease.

Guérin AP, Pannier B, Marchais SJ, London GM.

Curr Hypertens Rep. 2008 Apr;10(2):107-11. Review.

PMID:
18474176
9.

Arterial calcification and stiffness in chronic kidney disease.

Kerr PG, Guerin AP.

Clin Exp Pharmacol Physiol. 2007 Jul;34(7):683-7. Review.

PMID:
17581230
10.

In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease.

Boulanger CM, Amabile N, Guérin AP, Pannier B, Leroyer AS, Mallat CN, Tedgui A, London GM.

Hypertension. 2007 Apr;49(4):902-8. Epub 2007 Feb 19.

PMID:
17309952
11.

Local shear stress and brachial artery functions in end-stage renal disease.

Verbeke FH, Agharazii M, Boutouyrie P, Pannier B, Guérin AP, London GM.

J Am Soc Nephrol. 2007 Feb;18(2):621-8. Epub 2007 Jan 3.

12.

Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency.

London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F.

J Am Soc Nephrol. 2007 Feb;18(2):613-20. Epub 2007 Jan 3.

13.

Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.

Guérin AP, Pannier B, Marchais SJ, London GM.

Curr Opin Nephrol Hypertens. 2006 Mar;15(2):105-10. Review.

PMID:
16481874
14.

Arterial structural and functional alterations in uraemia.

Guérin AP, Marchais SJ, Metivier F, London GM.

Eur J Clin Invest. 2005 Dec;35 Suppl 3:85-8. Review.

PMID:
16281963
15.

Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia.

London GM, Marchais SJ, Guérin AP, Métivier F.

Curr Opin Nephrol Hypertens. 2005 Nov;14(6):525-31. Review.

PMID:
16205470
16.

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.

Amabile N, Guérin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM.

J Am Soc Nephrol. 2005 Nov;16(11):3381-8. Epub 2005 Sep 28.

17.

Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients.

Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM.

Hypertension. 2005 Apr;45(4):592-6. Epub 2005 Mar 7.

PMID:
15753232
18.

Arterial stiffness: pathophysiology and clinical impact.

London GM, Marchais SJ, Guerin AP, Pannier B.

Clin Exp Hypertens. 2004 Oct-Nov;26(7-8):689-99. Review.

PMID:
15702623
19.

Cardiovascular disease in renal failure.

Guerin AP, Adda H, London GM, Marchais SJ.

Minerva Urol Nefrol. 2004 Sep;56(3):279-88. Review.

20.

Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers.

Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, Cardoso C, Noël LH, Guérin AP, London GM, Jungers P.

Kidney Int. 2004 Oct;66(4):1606-12.

21.

Arterial stiffness and function in end-stage renal disease.

London GM, Marchais SJ, Guerin AP.

Adv Chronic Kidney Dis. 2004 Apr;11(2):202-9. Review.

PMID:
15216492
22.

Arterial calcifications and bone histomorphometry in end-stage renal disease.

London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC.

J Am Soc Nephrol. 2004 Jul;15(7):1943-51.

23.

Forearm reactive hyperemia and mortality in end-stage renal disease.

London GM, Pannier B, Agharazii M, Guerin AP, Verbeke FH, Marchais SJ.

Kidney Int. 2004 Feb;65(2):700-4.

24.

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H.

Nephrol Dial Transplant. 2003 Sep;18(9):1731-40.

PMID:
12937218
25.

Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients.

London GM, Marchais SJ, Guerin AP, Metivier F, Adda H, Pannier B.

Kidney Int Suppl. 2003 May;(84):S88-93.

PMID:
12694318
26.

Aortic pulse wave velocity index and mortality in end-stage renal disease.

Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM.

Kidney Int. 2003 May;63(5):1852-60.

27.

Prognostic significance of arterial stiffness measurements in end-stage renal disease patients.

Blacher J, Safar ME, Pannier B, Guerin AP, Marchais SJ, London GM.

Curr Opin Nephrol Hypertens. 2002 Nov;11(6):629-34. Review.

PMID:
12394609
28.

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

Drüeke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ, Gausson V, London GM.

Circulation. 2002 Oct 22;106(17):2212-7.

PMID:
12390950
29.

Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach.

London GM, Marchais SJ, Guérin AP, Métivier F.

Nephrol Dial Transplant. 2002;17 Suppl 11:13-5. Review.

PMID:
12386250
30.

Arterial structure and function in end-stage renal disease.

London GM, Marchais SJ, Guerin AP, Metivier F, Adda H.

Nephrol Dial Transplant. 2002 Oct;17(10):1713-24. No abstract available.

PMID:
12270974
31.

Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.

Pannier BM, Guerin AP, Marchais SJ, London GM.

Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1074-7.

PMID:
11903319
32.

Central pulse pressure and mortality in end-stage renal disease.

Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM.

Hypertension. 2002 Mar 1;39(3):735-8.

PMID:
11897754
33.

Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study.

London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME.

J Am Soc Nephrol. 2001 Dec;12(12):2759-67.

34.

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.

Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM.

Hypertension. 2001 Oct;38(4):938-42.

PMID:
11641313
35.

Arterial wave reflections and survival in end-stage renal failure.

London GM, Blacher J, Pannier B, Guérin AP, Marchais SJ, Safar ME.

Hypertension. 2001 Sep;38(3):434-8.

PMID:
11566918
36.

Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM.

Circulation. 2001 Feb 20;103(7):987-92.

PMID:
11181474
37.

Cardiovascular risk in end-stage renal disease: vascular aspects.

London GM, Marchais SJ, Metivier F, Guerin AP.

Nephrol Dial Transplant. 2000;15 Suppl 5:97-104. Review. No abstract available.

PMID:
11073281
38.

Pathophysiology of anaemia: focus on the heart and blood vessels.

Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM.

Nephrol Dial Transplant. 2000;15 Suppl 3:14-8. Review.

PMID:
11032352
39.

Pathophysiology of cardiovascular disease in hemodialysis patients.

Meeus F, Kourilsky O, Guerin AP, Gaudry C, Marchais SJ, London GM.

Kidney Int Suppl. 2000 Aug;76:S140-7. Review.

PMID:
10936811
40.

Arterial stiffening and vascular calcifications in end-stage renal disease.

Guérin AP, London GM, Marchais SJ, Metivier F.

Nephrol Dial Transplant. 2000 Jul;15(7):1014-21.

PMID:
10862640
41.

Calcification of the aortic valve in the dialyzed patient.

London GM, Pannier B, Marchais SJ, Guerin AP.

J Am Soc Nephrol. 2000 Apr;11(4):778-83. Review. No abstract available.

42.

Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease.

Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar ME, London GM.

Kidney Int. 2000 Mar;57(3):1091-9.

43.

Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease.

Blacher J, Demuth K, Guerin AP, Vadez C, Moatti N, Safar ME, London GM.

J Nephrol. 1999 Jul-Aug;12(4):248-55.

PMID:
10493568
44.

Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease.

Marchais SJ, Metivier F, Guerin AP, London GM.

Nephrol Dial Transplant. 1999 Sep;14(9):2178-83.

PMID:
10489228
45.

Influence of arterial pulse and reflected waves on blood pressure and cardiac function.

London GM, Guerin AP.

Am Heart J. 1999 Sep;138(3 Pt 2):220-4. Review.

PMID:
10467216
46.

Impact of aortic stiffness on survival in end-stage renal disease.

Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM.

Circulation. 1999 May 11;99(18):2434-9.

PMID:
10318666
47.

Large artery structure and function in hypertension and end-stage renal disease.

London GM, Guerin AP, Pannier B, Marchais SJ, Safar ME.

J Hypertens. 1998 Dec;16(12 Pt 2):1931-8. Review.

PMID:
9886879
48.

Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease.

Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM.

Hypertension. 1998 Sep;32(3):570-4.

PMID:
9740628
49.

Influence of body height on pulsatile arterial hemodynamic data.

Smulyan H, Marchais SJ, Pannier B, Guerin AP, Safar ME, London GM.

J Am Coll Cardiol. 1998 Apr;31(5):1103-9.

50.

Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease.

Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM.

Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):535-41.

PMID:
9555858

Supplemental Content

Loading ...
Support Center